Research and education at IGP
Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital.
Find examples of research at the department in Our research in images
New research findings from IGP
-
Beta blockers can repair malformed blood vessels in the brain
Propranolol, a drug that is efficacious against infantile haemangiomas (“strawberry naevi”, resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere. This has been shown by IGP researchers in a new study published in the scientific journal Stroke.
-
Innate immune system aggravates severe COVID-19
In critically ill COVID-19 patients, the innate immune system is strongly activated which can cause thrombosis and reduced oxygenation in the patients. This is shown in a study from IGP, published in the journal Frontiers in Immunology.
-
Metabolic response behind reduced cancer cell growth
Researchers from IGP show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
News
- Three IGP researchers granted funding by the Swedish Heart-Lung Foundation
- The Swedish Childhood Cancer Foundation supports a record number of IGP researchers
- Research grants from the Sjöberg Foundation to two IGP researchers
- Lars Forsberg receives ERC Consolidator Grant
- VR grant to infrastructure led by Ulf Gyllensten
Newsletter
Twitter IGP
- RT @KAWstiftelsen: Läs om uppsalaforskarna som vill hitta nya behandlingar mot obotliga hjärntumörer. De utvecklar en immunterapi med lova…
- Läs om uppsalaforskarna som vill hitta nya behandlingar mot obotliga hjärntumörer. De utvecklar en immunterapi med lovande resultat #KAW100 #cancer #hjärntumör #forskning @uppsalauni #immunterapi https://t.co/rpsQPDGWvT
- Grattis till Åsa Johansson, Marcel den Hoed och Bo Nilsson som beviljats forskningsmedel från Hjärt-Lungfonden https://t.co/0LEe7MZ9RD @hjartlungfonden